Global Health Investment Corporation — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Biosyntheticbiosynthetic.cominJun 2025 · $56M
Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US
Allen Barbieri(Executive Officer, Director)inDr. Matt Kriech(CEO)
BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)
Co-investorsHG VenturesAthosCivilization Ventures Management, LlcIn-Q-TelSherpalo VenturesViking Global Investors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.